📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Origo Biopharma

1.1 - Company Overview

Origo Biopharma Logo

Origo Biopharma

Headquarter: Spain
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of research and development of immunotherapeutic products targeting health disorders related to TGF-beta signaling dysfunction, including cancer and fibrosis.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Origo Biopharma

ThromboDx Logo

ThromboDx

HQ: The Netherlands Website
  • Description: Provider of blood-based, platelet-powered molecular diagnostics, developed and commercialized through a proprietary technology platform that addresses the need for an easily accessible, minimally invasive source; with offices in Amsterdam, The Netherlands.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ThromboDx company profile →
Artbio Logo

Artbio

HQ: United States Website
  • Description: Provider of clinical-stage alpha radioligand medicines and enabling technologies, including AB001, a 212Pb-based radiopharmaceutical candidate for prostate cancer in Phase I/II trials; AlphaDirect technology for isolating Pb-212 to enable distributed manufacturing; and a distributed end-to-end manufacturing network to deliver therapeutic candidates rapidly and flexibly.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Artbio company profile →
IsoRay Logo

IsoRay

HQ: United States Website
  • Description: Provider of state-of-the-art, personalized brachytherapy products that offer more cost-effective cancer treatment, utilizing a unique isotope for the treatment of both common and difficult-to-treat cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IsoRay company profile →
Femasys Logo

Femasys

HQ: United States Website
  • Description: Provider of medical device R&D and manufacturing for women’s healthcare, offering FemCerv, an FDA-cleared endocervical sampler; FemBloc, a nonsurgical in-office procedure for permanent contraception via fallopian tube blockage with a biopolymer using a proprietary delivery platform; and FemVue, an FDA-cleared product for real-time fallopian tube evaluation using saline and air contrast with ultrasound in a GYN’s office.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Femasys company profile →
Precision Biologics Logo

Precision Biologics

HQ: United States Website
  • Description: Provider of clinical-stage therapeutic and diagnostic products for the early detection and treatment of cancer, including monoclonal antibody drug candidates NEO-201 and Ensituximab (NEO-102), companion diagnostics (IHC and serum ELISA) to predict and monitor patient response, and clinical trials evaluating the efficacy of their therapeutic antibodies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Precision Biologics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Origo Biopharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Origo Biopharma

2.2 - Growth funds investing in similar companies to Origo Biopharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Origo Biopharma

4.2 - Public trading comparable groups for Origo Biopharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Origo Biopharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Origo Biopharma

What does Origo Biopharma do?

Origo Biopharma is a provider of research and development of immunotherapeutic products targeting health disorders related to TGF-beta signaling dysfunction, including cancer and fibrosis.

Who are Origo Biopharma's competitors?

Origo Biopharma's competitors and similar companies include ThromboDx, Artbio, IsoRay, Femasys, and Precision Biologics.

Where is Origo Biopharma headquartered?

Origo Biopharma is headquartered in Spain.

How many employees does Origo Biopharma have?

Origo Biopharma has 1,000 employees 🔒.

When was Origo Biopharma founded?

Origo Biopharma was founded in 2010 🔒.

What sector and industry vertical is Origo Biopharma in?

Origo Biopharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Origo Biopharma

Who are the top strategic acquirers in Origo Biopharma's sector and industry

Top strategic M&A buyers and acquirers in Origo Biopharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Origo Biopharma?

Top strategic M&A buyers groups and sectors for Origo Biopharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Origo Biopharma's sector and industry vertical

Which are the top PE firms investing in Origo Biopharma's sector and industry vertical?

Top PE firms investing in Origo Biopharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Origo Biopharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Origo Biopharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Origo Biopharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Origo Biopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Origo Biopharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Origo Biopharma?

The key public trading comparables and valuation benchmarks for Origo Biopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Origo Biopharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Origo Biopharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Origo Biopharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Origo Biopharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Origo Biopharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Origo Biopharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Origo Biopharma